ENTPD1 and neoplasm: On the contrary, CD39 expression is increased on tumor‐infiltrating Treg in many oncological settings, including solid malignancies such as colon carcinoma,23 gastric cancer,24 head and neck cancer25 as well as hematological malignancies26, 27, 28 and is associated with poor prognosis and lower overall survival.